Form 8-K - Current report:
SEC Accession No. 0001437749-25-026511
Filing Date
2025-08-13
Accepted
2025-08-13 16:13:23
Documents
14
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20250813_8k.htm   iXBRL 8-K 30094
2 EXHIBIT 99.1 ex_852503.htm EX-99.1 118390
  Complete submission text file 0001437749-25-026511.txt   288411

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250813.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250813_def.xml EX-101.DEF 11056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250813_lab.xml EX-101.LAB 14798
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250813_pre.xml EX-101.PRE 11161
16 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250813_8k_htm.xml XML 2775
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 251211740
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)